BlueRemediomics partners Abbe Brown (University of Aberdeen) and Davids Fridmanis (Latvian Biomedical Research and Study Center) are participating in a public engagement event along with
Last month, BlueRemediomics partners came together for three days in the Latvian capital to present updates and discuss the project’s progress and challenges. Hosted by
BlueRemediomics partners from the University of Aberdeen and ABS International/3BIO co-organised a workshop on Article 12 of the Agreement and served as Rapporteurs during the BBNJ Symposium in Singapore
Originally published by CORDIS. Can seaweed help reduce inflammation in farmed fish? An EU-backed study investigates. A recent study carried out by Norwegian and Spanish researchers explores
February 20 is World Day of Social Justice, an opportunity to show how BlueRemediomics partners are working to improve Access and Benefit-Sharing (ABS), to ensure
More than twenty researchers from across the world have come together to publish a collaborative book, ‘Decoding Marine Genetic Resource Governance Under the BBNJ Agreement’,
BlueRemediomics partners Prof. Marcel Jaspars (University of Aberdeen) and Thomas Vanagt (3BIO) in collaboration with Fran Humphries (Griffith University) are organising a satellite event at
Return of the schooner Tara and the EMBL mobile laboratory after an unprecedented 18-month land-sea expedition On October 5th 2024, the scientific schooner Tara returned
The concept of “doing no significant harm” runs through the EU Horizon Europe project BlueRemediomics, and has been explored in the past in “Town Hall”
In time for the Sixteenth meeting of the Conference of the Parties to the Convention on Biological Diversity (COP 16) taking place from the 21st of October